Aspen Aerogels Q3 EPS $(0.19) Beats $(0.30) Estimate, Sales $60.76M Beat $50.80M Estimate
Portfolio Pulse from totan@benzinga.com
Aspen Aerogels (NYSE:ASPN) reported Q3 losses of $(0.19) per share, beating the analyst consensus estimate of $(0.30) by 36.67%. This is a 74.67% increase over losses from the same period last year. The company also reported quarterly sales of $60.76 million, beating the analyst consensus estimate of $50.80 million by 19.60%. This is a 65.52% increase over sales from the same period last year.
November 01, 2023 | 9:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aspen Aerogels reported better than expected Q3 results with losses per share and sales beating estimates. The company's losses per share improved by 74.67% YoY and sales increased by 65.52% YoY.
Aspen Aerogels reported better than expected Q3 results, with both losses per share and sales beating analyst estimates. This indicates a strong financial performance, which is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100